Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U8 small nucleolar RNA is a vertebrate-specific non-coding RNA that forms part of a small nucleolar ribonucleoprotein complex (snoRNP) essential for the biogenesis of the large subunit of ribosomes. Encoded by the SNORD118 gene in humans, U8 snoRNA is classified as a C/D box snoRNA but is unusual in that it is not involved in 2'-O-methylation of rRNA. Instead, U8 is directly required for the cleavage and correct processing of precursor rRNA to yield mature 5.8S and 28S rRNAs, thereby enabling ribosome assembly. U8 snoRNA mutations lead to the rare neurodegenerative condition known as leukoencephalopathy with brain calcifications and cysts (LCC or Labrune syndrome), making SNORD118 a disease gene but not a typical drug or therapeutic protein target[2][3][1][4][5]. U8 is found only in vertebrates and is absent from yeast and most non-vertebrate eukaryotes. Although upregulation of U8 has been observed in certain cancers, its role as a therapeutic target or biomarker remains unclear[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U8 small nucleolar RNA (U8).